Transcriptional fidelity enhances cancer cell line selection in pediatric cancers
暂无分享,去创建一个
M. Sirota | R. Okimoto | K. Yu | Cuyler Luck | Katharine Yu
[1] Joshua M. Dempster,et al. A First-Generation Pediatric Cancer Dependency Map , 2021, Nature Genetics.
[2] A. Jemal,et al. Cancer Statistics, 2021 , 2021, CA: a cancer journal for clinicians.
[3] J. Mora,et al. Comprehensive Biology and Genetics Compendium of Wilms Tumor Cell Lines with Different WT1 Mutations , 2020, Cancers.
[4] F. Westermann,et al. Super enhancers define regulatory subtypes and cell identity in neuroblastoma , 2020, Nature Cancer.
[5] James M. McFarland,et al. Global computational alignment of tumor and cell line transcriptional profiles , 2020, Nature Communications.
[6] A. Peraud,et al. Compare and contrast: pediatric cancer versus adult malignancies , 2019, Cancer and Metastasis Reviews.
[7] Svenn-Arne Dragly,et al. Perineuronal nets stabilize the grid cell network , 2019, bioRxiv.
[8] A. Butte,et al. Comprehensive transcriptomic analysis of cell lines as models of primary tumors across 22 tumor types , 2019, Nature Communications.
[9] M. Salvatore,et al. Cancer Cell Lines Are Useful Model Systems for Medical Research , 2019, Cancers.
[10] D. Nam,et al. Relevance of a TCGA-derived Glioblastoma Subtype Gene-Classifier among Patient Populations , 2019, Scientific Reports.
[11] Joshua M. Korn,et al. Next-generation characterization of the Cancer Cell Line Encyclopedia , 2019, Nature.
[12] G. G. Galli,et al. The landscape of cancer cell line metabolism , 2019, Nature Medicine.
[13] J. Biegel,et al. The genomic landscape of pediatric cancers: Implications for diagnosis and treatment , 2019, Science.
[14] Axel Meyer,et al. Asymmetric paralog evolution between the “cryptic” gene Bmp16 and its well-studied sister genes Bmp2 and Bmp4 , 2019, Scientific Reports.
[15] M. Resnick. Re: The Cumulative Burden of Surviving Childhood Cancer: An Initial Report from the St Jude Lifetime Cohort Study (SJLIFE). , 2018, The Journal of urology.
[16] Michael C. Heinold,et al. The landscape of genomic alterations across childhood cancers , 2018, Nature.
[17] Michael W. Bishop,et al. The Cumulative Burden of Surviving Childhood Cancer: An Initial Report from the St. Jude Lifetime Cohort Study , 2017, The Lancet.
[18] Phillip G. Montgomery,et al. Defining a Cancer Dependency Map , 2017, Cell.
[19] Yiling Lu,et al. Characterization of Human Cancer Cell Lines by Reverse-phase Protein Arrays. , 2017, Cancer cell.
[20] B. Coyle,et al. In vitro models of medulloblastoma: Choosing the right tool for the job. , 2016, Journal of biotechnology.
[21] D.P. Ivanov,et al. Data on the number and frequency of scientific literature citations for established medulloblastoma cell lines , 2016, Data in brief.
[22] Thomas D. Wu,et al. A comprehensive transcriptional portrait of human cancer cell lines , 2014, Nature Biotechnology.
[23] P. Dallas,et al. Gene Expression Analyses of the Spatio-Temporal Relationships of Human Medulloblastoma Subgroups during Early Human Neurogenesis , 2014, PloS one.
[24] Puja Gupta,et al. Late effects in adult survivors of pediatric cancer: a guide for the primary care physician. , 2012, The American journal of medicine.
[25] Guangchuang Yu,et al. clusterProfiler: an R package for comparing biological themes among gene clusters. , 2012, Omics : a journal of integrative biology.
[26] S. Ramaswamy,et al. Systematic identification of genomic markers of drug sensitivity in cancer cells , 2012, Nature.
[27] Adam A. Margolin,et al. The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity , 2012, Nature.
[28] Davis J. McCarthy,et al. Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation , 2012, Nucleic acids research.
[29] Scott L. Pomeroy,et al. Molecular subgroups of medulloblastoma: the current consensus , 2011, Acta Neuropathologica.
[30] S. Gabriel,et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. , 2010, Cancer cell.
[31] Mark D. Robinson,et al. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..
[32] M. Robinson,et al. A scaling normalization method for differential expression analysis of RNA-seq data , 2010, Genome Biology.
[33] D. Osuna,et al. Advances in Ewing's sarcoma research: where are we now and what lies ahead? , 2009, Cancer research.
[34] E. Birney,et al. Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRt , 2009, Nature Protocols.
[35] M. Robinson,et al. Small-sample estimation of negative binomial dispersion, with applications to SAGE data. , 2007, Biostatistics.
[36] Mark D. Robinson,et al. Moderated statistical tests for assessing differences in tag abundance , 2007, Bioinform..
[37] Cheng Li,et al. Adjusting batch effects in microarray expression data using empirical Bayes methods. , 2007, Biostatistics.
[38] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[39] Bart De Moor,et al. BioMart and Bioconductor: a powerful link between biological databases and microarray data analysis , 2005, Bioinform..
[40] M. Daly,et al. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.
[41] John R. W. Masters,et al. Human cancer cell lines: fact and fantasy , 2000, Nature Reviews Molecular Cell Biology.